Toll-like Receptor 4 Asp299Gly Gene Polymorphism and Risk of Atherothrombosis
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (1) , 154-157
- https://doi.org/10.1161/01.str.0000149948.31879.f0
Abstract
Background and Purpose— Recent findings of an association between a functional toll-like receptor 4 ( TLR4 ) D299G gene variant and reduced risk of atherothrombotic disorders have generated great interest. Methods— We evaluated the TLR4 D299G polymorphism among 695 individuals with incident myocardial infarction (MI) or stroke and among 695 age- and smoking-matched individuals who remained free of reported cardiovascular disease during follow-up within the Physicians’ Health Study. Results— Overall, we observed little evidence of association between the D299G polymorphism and risk of any atherothrombotic event ( P =0.25), incident MI ( P =0.89), or stroke ( P =0.09), assuming an additive model. Adjusting for traditional cardiovascular risk factors or assuming a dominant model yielded similar null findings. Whereas the observed carrier frequency of the D299G polymorphism in our data (13.0%) is consistent with those observed in most other studies, it was higher than the 6.8% carrier frequency observed in the initial study that suggested a protective effect for this gene variant. Thus, this former association may have been caused, in part, by an underestimation of the control frequency. Conclusion— In contrast to previous data, the D299G TLR4 polymorphism was not associated with risk of incident MI or stroke in this large prospective study of US men.Keywords
This publication has 14 references indexed in Scilit:
- Toll‐like receptor‐4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemiaEuropean Journal of Clinical Investigation, 2004
- Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosisAtherosclerosis, 2003
- Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathwayProceedings of the National Academy of Sciences, 2003
- Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular EventsCirculation, 2003
- Toll-like Receptor 4 Polymorphisms and AtherogenesisNew England Journal of Medicine, 2002
- Expression of Toll-Like Receptors in Human Atherosclerotic LesionsCirculation, 2002
- TLR4 mutations are associated with endotoxin hyporesponsiveness in humansNature Genetics, 2000
- Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardiumJournal of Clinical Investigation, 1999
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989